Maine 2025-2026 Regular Session

Maine House Bill LD886

Introduced
3/4/25  
Refer
3/4/25  
Refer
3/4/25  

Caption

An Act to Regulate Medication Abortions

Impact

The implications of LD886 are significant as it tightens control over medication abortions in the state. By mandating that individuals cannot obtain medication abortions through online means and requiring in-person oversight from healthcare professionals, the bill aims to ensure that patients are adequately informed about the procedures and potential risks involved. This might limit access for some individuals, particularly those in remote areas where healthcare providers may not be readily available.

Summary

LD886 is a legislative proposal aiming to regulate medication abortions specifically through stringent requirements on how these procedures can be accessed and administered. The bill stipulates that individuals seeking a medication abortion must obtain a prescription from a licensed healthcare professional who must also oversee the abortion in person. Additionally, the purchase of chemical agents or drugs used for medication abortions via online sources is explicitly prohibited, reinforcing the need for direct healthcare provider involvement in the process.

Sentiment

Discussions surrounding LD886 have generated polarized sentiment. Supporters argue that the bill enhances patient safety and ensures that necessary medical oversight is provided during medication abortions. They believe these regulations will protect women and promote responsible healthcare practices. Conversely, opponents of the bill view it as an infringement on women's rights to access safe and timely abortions, describing the restrictions as unnecessary barriers that could force women into less safe alternatives.

Contention

Notable points of contention center around the perceived motivations behind the bill. Critics raise concerns that the restrictions could disproportionately affect low-income individuals and violate personal autonomy by limiting how women can obtain healthcare. Furthermore, the inclusion of information about reversing medication abortions has sparked debate regarding medical accuracy and the ethical implications of such claims. The conflict embodies broader societal debates around reproductive rights and the regulation of women's health services.

Companion Bills

No companion bills found.

Previously Filed As

ME A09198

Enacts the "life appropriation act" prohibiting state funding for abortions and related costs; regulates abortions and prohibits dismemberment abortions.

ME HB236

Notice For Medication Abortions

ME S1095

Prohibit Abortions

ME HF2788

A bill for an act relating to abortions including definitions, informed consent, dispensing of abortion-inducing drugs, and other abortion-related provisions. (Formerly HF 2563, HSB 704.) Effective date: 07/01/2026.

ME SSB3115

A bill for an act relating to abortions including informed consent, dispensing abortion-inducing drugs, and reporting abortion-inducing drug complications.

ME HSB704

A bill for an act relating to abortions including informed consent, dispensing abortion-inducing drugs, and reporting abortion-inducing drug complications.(See HF 2563, HF 2788.)

ME HF2563

A bill for an act relating to abortions including informed consent, dispensing abortion-inducing drugs, and reporting abortion-inducing drug complications.(Formerly HSB 704; See HF 2788.)

ME HF775

A bill for an act relating to medication abortions including required informed consent and the dispensing of abortion-inducing drugs to patients within the state.(Formerly HSB 186.)

ME HSB186

A bill for an act relating to medication abortions including required informed consent and the dispensing of abortion-inducing drugs to patients within the state.(See HF 775.)

ME HB2419

Modifies provisions relating to medication abortion

Similar Bills

No similar bills found.